rs201927653
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198253.3(TERT):c.1931C>T(p.Thr644Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.1931C>T | p.Thr644Met | missense_variant | 4/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.1931C>T | p.Thr644Met | missense_variant | 4/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.2010C>T | non_coding_transcript_exon_variant | 4/13 | ||||
TERT | NR_149163.3 | n.2010C>T | non_coding_transcript_exon_variant | 4/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.1931C>T | p.Thr644Met | missense_variant | 4/16 | 1 | NM_198253.3 | ENSP00000309572.5 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152240Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251334Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135860
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461742Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727164
GnomAD4 genome AF: 0.000197 AC: 30AN: 152358Hom.: 0 Cov.: 34 AF XY: 0.000148 AC XY: 11AN XY: 74504
ClinVar
Submissions by phenotype
Immunodeficiency;C0024117:Chronic obstructive pulmonary disease;C0401151:Chronic diarrhea;C4048270:Decreased circulating antibody concentration Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Jul 29, 2021 | ACMG classification criteria: PS4 supporting, PP2 supporting, BP4 supporting - |
Aplastic anemia;C0023467:Acute myeloid leukemia;C3151443:Dyskeratosis congenita, autosomal dominant 2;C3553617:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;C3554574:Melanoma, cutaneous malignant, susceptibility to, 9;C4551974:Dyskeratosis congenita, autosomal dominant 1;C5561926:Interstitial lung disease 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 26, 2021 | - - |
Dyskeratosis congenita, autosomal dominant 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 28, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25346280, 30523342) - |
Dyskeratosis congenita Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2024 | The p.T644M variant (also known as c.1931C>T), located in coding exon 4 of the TERT gene, results from a C to T substitution at nucleotide position 1931. The threonine at codon 644 is replaced by methionine, an amino acid with similar properties. This variant was reported in multiple individuals with features consistent with TERT-related disorder (Dai J et al. Respirology, 2015 Jan;20:122-8; Gutierrez-Rodrigues F et al. Genet Med, 2019 Jul;21:1594-1602; Kapuria D et al. Hepatology, 2019 Jun;69:2579-2585). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. - |
TERT-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The TERT c.1931C>T variant is predicted to result in the amino acid substitution p.Thr644Met. This variant was reported in individuals with idiopathic pulmonary fibrosis or a suspected telomeropathy (Dai et al. 2015. PubMed ID: 25346280, reported as T644M; Gutierrez-Rodrigues et al 2018. PubMed ID: 30523342, supplementary data). This variant is reported in 0.060% of alleles in individuals of African descent in gnomAD. This variant has conflicting interpretations in ClinVar from uncertain significance to likely benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/410674/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at